CINCLUS PHARMA’S NOMINATION COMMITTEE FOR THE 2025 ANNUAL GENERAL MEETING APPOINTED
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Mid Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Bioteknik |
According to the principles for the appointment of the Nomination Committee in Cinclus Pharma Holding AB (publ), adopted by the Annual General Meeting 2024, the Nomination Committee for the Annual General Meeting 2025 shall be composed of members appointed by the three largest shareholders as of September 30, 2024 along with the Chairman of the Board of Directors.
The composition of the Nomination Committee has now been established, and the company
today announces that the Nomination Committee for the 2025 Annual General Meeting consists
of the following members:
Bita Sehat, appointed by Trill Impact Ventures Pharma 1 AB
Karl Tobieson, appointed by Linc AB
Elin Häggbom, appointed by PetoMaj Invest AB
Lennart Hansson, Chairman of the Board, is an acting member of the Nomination Committee.
The shareholders who have appointed members to the Nomination Committee together represent approximately 17.4 percent of all shares in Cinclus Pharma Holding AB (publ) as of September 30, 2024.
Cinclus Pharma Holding AB (publ)’s Annual General Meeting will be held on Thursday May 22, 2025.
The Nomination Committee shall submit proposals for resolution by the 2025 General Meeting pertaining to the election of Chairman of the Meeting, fees and composition of the Board, auditors’ fees and the election of auditors and, if necessary, proposal for changes in the instruction to the Nomination Committee. The Nomination Committee’s proposals will be presented in the Notice to the Annual General Meeting 2025 and on Cinclus Pharma’s website, www.cincluspharma.com.
Shareholders wishing to submit proposals to the Nomination Committee can do so by sending an e-mail to corporate@cincluspharma.com (subject “Nomination Committee”) or by letter posted to Cinclus Pharma Holding AB (publ), Attn: CFO Maria Engström, Kungsbron 1, SE-111 22, Stockholm, Sweden.
Proposals should, in order to be timely assessed by the Nomination Committee, be submitted no later than February 28, 2025.